4Shirasaka T, Nakano K, Takechi T, et al. Antitumor activity of 1 M tega- fur-0. 4 M5-chloro-2,4-dihydroxypyridine-1 M potassium oxonate (S- 1 )against human colon carcinoma orthotopically implanted into nude rats [ J ]. Cancer Res, 1996,56:2602 - 2606. 被引量：1
5Hoff PM. The tegafur-based dihydropyrimidine dehydrogenase inhibitoryfluoropyrimidines, UFT/leucovorin (0RZEL) and S-1 : a review of their clinical development and therapeutic potential [ J ]. Invest New Drugs, 2000,18:331 -342. 被引量：1
6Fukushima M,Morita M, Ikeda K, et al. Population study of expression of thymidylate synthase and dihydropyrimidine dehydrogenase in pa- tients with solid tumors [ J ]. Int J Mol Med,2003,12:839 - 844. 被引量：1
7Kawahara M, Furuse K, Segawa Y, et al. Phase Ⅱ study of S-1, a novel oral fluo-rouracil, in advanced non-small-cell lung cancer [ J ]. Br J Cancer,2001,85:939 - 943. 被引量：1
8Isamu Okamoto, Hiroshige Yoshioka, Phase Ⅲ Trial Comparing Oral S- 1 Plus Carboplatin With Paelitaxel Plus Carboplatin in Chemotherapy- Naive Patients With Advanced Non-Small-Cell Lung Cancer:Results of a West Japan Oneology Group Study[J]. JCO VOLUME, 20,2010. 被引量：1
9Yamamoto N, Ichinose Y, Kubota K, Sakai H, Gemma A, Saijo N, et al. Jpn J Lung Cancer (Haigan) ,2008,48:432. 被引量：1
10Malone P, Rossi A, Sacco PC, et al. Advances in chemother- apy in advanced non-small-cell lung cancer [ J ] Expert Opin Pharmacother ,2010,11 ( 18 ) :2997. 被引量：1
